Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
37,047
Sort by:
Grifols, Ivig Opportunity In Ad - Dark Knight
US$ 140.00
... core business, bonus upside from positive data of IVIG in AD, and an attractive risk-reward profile, Grifols SA (GRF) is our preferred choice among three ... coverage initiation report released on 22nd Oct., 2012 on GRF titled, “GRIFOLS SA - IVIG Opportunity in AD - Dark Knight”.
October 2012
17 pages
Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022
US$ 2,401.00
... ? Our study also covers 20 other companies following after the world leaders. You discover activities of organisations including the following: BioDiem CoMentis ... will develop and prosper, our analysis shows. Nine ways Pharma Leader Series: Top 20 Ophthalmic Drug Manufacturers 2012-2022 benefits you To ...
October 2012
166 pages
Global Pharmaceutical Market Report & Forecast: 2012-2017
US$ 1,400.00
The global pharmaceutical market is expected to grow at a CAGR of 5% during 2011-2017, exceeding sales worth US$ 1.1 Trillion by 2017. This market, however, is expected to undergo a number of transiti...
October 2012
Alzherimer's Drugs Market, 2012-2017
US$ 1,699.00
... five years, from 2012-2017, will see the launch of many new drugs. Scope of the Report The Alzheimer’s drug market (2011-2017) ... III clinical trials. Chapter 8 provides profiles of the key companies in this market. Each company profile includes information such as financial performance, geographical ...
October 2012
117 pages
Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022
US$ 2,401.00
... - you see prospects to 2022 for Sandoz Will Sandoz remain the market leader? See information on its activities in 2012, looking ahead. You find discussion ... leading generics specialists - will develop and prosper. Eight ways Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2012-2022 helps you To ...
October 2012
182 pages
Competitor Analysis: Pneumococcal and Streptococcal Vaccines
US$ 260.00
... , Company, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, ...
October 2012
21 pages
The US Specialty Pharmaceutical Market Report: 2012 Edition
US$ 800.00
... which fall within the bounds of specialty pharmaceuticals. There is no particular definition for specialty pharmaceutical but on the basis of some ... overview of the US specialty pharmaceutical market covering various disease segments and the specialty pharmacy market. The specialty pharma realm is intensely ...
September 2012
65 pages
Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
US$ 3,995.00
... past year, and these are covered in this report Vaccines 2012: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing ... elderly populations. This report includes profiles of the key players in vaccines, including: AlphaVax, Inc. Bavarian Nordic A/S Baxter Healthcare Bharat Biotech ...
September 2012
249 pages
Data report-Production Situation of Vitamin B2
US$ 1,490.00
... This report provides you concise information about the vitamin B2 industry in China, discovering not only the latest dynamics of production situation and producers ... , but also price, import and export, and the application fields of the vitamin B2 products. Besides, ...
September 2012
13 pages
World Multiple Myeloma Drug Treatment Market 2012-2022
US$ 2,635.00
... will arise for companies treating cancers. Nine ways World Multiple Myeloma Drug Treatment Market 2012-2022 helps you In particular, then, ... following knowledge on the topic: Forecasted revenue to 2022 for the overall world market - find the industry's prospects Potential revenues of 10 products to 2022 ...
September 2012
136 pages
The World Market for Transdermal Drug Delivery
US$ 2,500.00
... and the ability to quickly discontinue treatment by removal of the system. This report, World Markets for Transdermal Drug Delivery is a comprehensive look at the ... , revenues have been reported that include pharmaceutical sales for products utilizing that technology. This market is divided into two segments ...
September 2012
100 pages
Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022
US$ 2,635.00
... top sales places. Also, most of those products will continue revenue growth. Seven ways Pharma Leader Series: Top 20 Biological Drug Manufacturers 2012-2022 helps you In particular, our report gives you the following knowledge on producers of biologics: Profiles of 20 leading ...
September 2012
187 pages
Competitor Analysis: Tuberculosis Vaccines and Therapeutics
US$ 516.00
... targeting Mycobacterium tuberculosis for prophylaxis and treatment of tuberculosis. In addition, the report lists corporate and public R&D pipelines of Tuberculosis Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action ...
September 2012
70 pages
Global Generic Drugs Industry 2012-2017: Trend, Profit, and Forecast Analysis, September 2012
US$ 1,980.00
... , a leading global management consulting and market research firm, has analyzed the global generic drugs industry and presents its findings in Global Generic Drugs Industry 2012-2017: Trend, Profit, and Forecast Analysis. The industry comprises firms primarily engaged in the development, manufacture, and marketing of generic drugs. The generic ...
September 2012
Pharma and Payers – Building Better Relationships
US$ 895.00
Changes in the healthcare landscape have put payers (public and private) under mounting pressure to reduce the cost of care, and given them much greater influence over market access to new medicines.I...
August 2012
67 pages
Pharmaceutical Contract Manufacturing: World Market Outlook 2012-2022
US$ 2,635.00
... . In our investigation you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses, including discussions of regulatory ... growth from this decade onwards. SEVEN WAYS PHARMACEUTICAL CONTRACT MANUFACTURING: WORLD MARKET OUTLOOK 2012-2022 BENEFITS YOU In particular, then, ...
August 2012
173 pages
Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022
US$ 2,635.00
... . This decade, many opportunities will arise. EIGHT WAYS LYOPHILISATION FOR PHARMACEUTICALS: PRODUCTS AND SERVICES MARKET 2012-2022 HELPS YOU ... (EU5), India and China Profiles of 5 leading companies - discussions of activities, products and outlooks Opinions on the sector, including our interviews with ...
August 2012
130 pages
Competitor Analysis: Malaria Vaccines & Therapeutics
US$ 390.00
... description The present Competitive Intelligence Report about Malaria Vaccines & Therapeutics provides a competitor evaluation in the field of investigational small molecules and ... regions. Each year more than 350 million new cases of Malaria occur, it is one of the world’s most common diseases. People with ...
August 2012
64 pages
Competitor Analysis: CMV Vaccines & Therapeutics
US$ 247.00
... approved for treatment or prevention of CMV disease, such as ganciclovir, or hyperimmune globulin preparations, but no specific CMV vaccine is approved. The present Competitor Analysis describes the R&D pipeline of new molecular entities including vaccines, monoclonal antibodies, peptides, cellular therapy ...
August 2012
23 pages
Pharma Reputations: Managing Perceptions
US$ 645.00
Pharma is no stranger to the idea of nurturing and defending corporate reputations. But in this hyper-connected world, Likes and Tweets are replacing traditional authority sources and creating a compl...
July 2012
69 pages
Pharma's Future Role in CME
US$ 595.00
... Dossier report: Pharma’s Future Role in CME. REPORT OVERVIEW Save time and effort by reviewing forecasts from 10 leading figures in the US and European CME fields ... role in future CME productions, or strategically direct these from the background. KEY REPORT FEATURES Recent and expected US and European CME regulations Latest pharma ...
July 2012
62 pages
World Vaccines Market 2012-2022
US$ 2,635.00
... and branded groups - including Prevnar-13, Pentacel, Gardasil and Fluzone - perform to 2022? Our investigation shows business research and analysis with sales ... receive 91 tables, 63 charts and a research interview. Eight ways World Vaccines Market 2012-2022 helps you In particular, our study gives you ...
July 2012
199 pages
Latest Guide to Chinese Pharmaceutical GMP Regulations
US$ 750.00
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB 1550 billion (about US$246 billion)...
July 2012
135 pages
OTC Triptans in Germany
US$ 990.00
... for a considerable further increase of category value sales in Germany in 2011. Euromonitor International's OTC Triptans in Germany report offers a comprehensive guide to the size and shape ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving change ...
July 2012
27 pages